India to New Zealand: Roxithromycin Export Trade Route
India has recorded 10 verified shipments of Roxithromycin exported to New Zealand, representing a combined trade value of $405.4K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $40.5K USD. The leading Indian exporter is MARKSANS PHARMA LIMITED, which accounts for 74% of total export value with 7 shipments worth $298.5K USD. On the buying side, TEVA PHARMA NEW ZEALAND LIMITED is the largest importer in New Zealand with $170.2K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to New Zealand Roxithromycin corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $405.4K USD. The route is dominated by MARKSANS PHARMA LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's roxithromycin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $40.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 24.7%, placing it at rank #14 among India's top roxithromycin export destinations globally.
On the import side, key buyers of Indian roxithromycin in New Zealand include TEVA PHARMA NEW ZEALAND LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED . TEVA PHARMA NEW ZEALAND LIMITED is the single largest importer with 5 shipments valued at $170.2K USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#14
- Annual growth+24.7%
- Demand growth+22.7%
- Regulatory ease69/100
Top 10 Indian Roxithromycin Exporters to New Zealand
Showing top 10 of 2 Indian suppliers exporting Roxithromycin to New Zealand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MARKSANS PHARMA LIMITED Avg $42.6K per shipment | 7 | $298.5K | 73.6% |
| 2 | MARKSANS PHARMA LIMITED Avg $35.6K per shipment | 3 | $106.9K | 26.4% |
This table shows the top 10 of 2 Indian companies exporting roxithromycin to New Zealand, ranked by total trade value. The listed exporters are: MARKSANS PHARMA LIMITED, MARKSANS PHARMA LIMITED . MARKSANS PHARMA LIMITED is the dominant supplier with 7 shipments worth $298.5K USD, giving it a 74% market share.
Top 10 Roxithromycin Importers in New Zealand
Showing top 10 of 3 known buyers in New Zealand receiving Roxithromycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian roxithromycin in New Zealand include TEVA PHARMA NEW ZEALAND LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED . The largest importer is TEVA PHARMA NEW ZEALAND LIMITED, accounting for $170.2K USD across 5 shipments — representing 42% of all roxithromycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TEVA PHARMA NEW ZEALAND LIMITED | 5 | $170.2K | 42.0% |
| 2 | TEVA PHARMA (NEW ZEALAND) LIMITED | 2 | $128.3K | 31.7% |
| 3 | TEVA PHARMA (NEW ZEALAND) LIMITED | 3 | $106.9K | 26.4% |
Top 10 Roxithromycin Formulations Imported by New Zealand
Showing top 10 of 10 product formulations shipped on the India to New Zealand Roxithromycin route, ranked by trade value
New Zealand imports a wide range of roxithromycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS - ROXITHROMYCIN300 MG TABLETS Batch No: 150507,150488,150506 — accounts for $108.1K USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS - ROXITHROMYCIN300 MG TABLETS Batch No: 150507,150488,150506 | 1 | $108.1K | 26.7% |
| 2 | ROXITHROMYCIN 150 MG TABLETS 12960 PACK | 1 | $45.3K | 11.2% |
| 3 | ROXITHROMYCIN 150 MG TABLETS (12030 PACK | 1 | $42.1K | 10.4% |
| 4 | ROXITHROMYCIN 300 MG TABLETS 5210 PACKX | 1 | $35.9K | 8.9% |
| 5 | PHARMA PRODUCTS-ROXITHROMYCIN 150 MG TABLETS BATCH NO: 131481 | 1 | $34.7K | 8.5% |
| 6 | ROXITHROMYCIN 300 MG TABLETS BATCH NO: 131482 | 1 | $34.3K | 8.5% |
| 7 | PHARMA PRODUCTS-ROXITHROMYCIN 300 MG TAB | 1 | $32.5K | 8.0% |
| 8 | ROXITHROMYCIN 300 MG TABLETS (4680 PACKX | 1 | $32.3K | 8.0% |
| 9 | ROXITHROMYCIN 150 MG TABLETS (5760 PACKX | 1 | $20.2K | 5.0% |
| 10 | ROXITHROMYCIN 150 MG TABLETS 5760 PACKX | 1 | $20.1K | 5.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 3 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's roxithromycin exports to New Zealand are driven primarily by a handful of large-scale manufacturers. MARKSANS PHARMA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MARKSANS PHARMA LIMITED, MARKSANS PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $40.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as roxithromycin 150 mg tablets 12960 pack and roxithromycin 150 mg tablets (12030 pack , suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TEVA PHARMA NEW ZEALAND LIMITED is the largest importer with 5 shipments worth $170.2K USD — representing 42% of all roxithromycin imports from India on this route.
Route Statistics
- Trade Volume
- $405.4K
- Avg. Shipment
- $40.5K
- Suppliers
- 2
- Buyers
- 3
- Transit (Sea)
- ~32 days
- Annual Growth
- +24.7%
Related Analysis
Other Roxithromycin Routes
Unlock the Full India to New Zealand Roxithromycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to New Zealand Roxithromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Roxithromycin to New Zealand?
The leading Indian exporters of Roxithromycin to New Zealand are MARKSANS PHARMA LIMITED, MARKSANS PHARMA LIMITED . MARKSANS PHARMA LIMITED holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Roxithromycin exports from India to New Zealand?
India exports Roxithromycin to New Zealand worth approximately $405.4K USD across 10 recorded shipments. The average value per shipment is $40.5K USD.
Q Which ports does India use to ship Roxithromycin to New Zealand?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to New Zealand for Roxithromycin?
The average transit time for Roxithromycin shipments from India to New Zealand is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to New Zealand Roxithromycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.7% with demand growth tracking at 22.7%. The route is ranked #14 among India's top Roxithromycin export destinations globally.
Q How many suppliers are active on the India to New Zealand Roxithromycin route?
There are currently 2 active Indian suppliers exporting Roxithromycin to New Zealand. The market is moderately concentrated with MARKSANS PHARMA LIMITED accounting for 74% of total shipment value.
Q Who are the main importers of Roxithromycin from India in New Zealand?
The leading importers of Indian Roxithromycin in New Zealand include TEVA PHARMA NEW ZEALAND LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED, TEVA PHARMA (NEW ZEALAND) LIMITED . TEVA PHARMA NEW ZEALAND LIMITED is the largest buyer with 5 shipments worth $170.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Roxithromycin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 3 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists